Free shipping on all orders over $ 500

 About 1 result found for searched term "1629853-48-0" (0.09 seconds)

Cat.No.  Name Target
M21052 SAGE-718 GluR
Dalzanemdor
Dalzanemdor (SAGE-718) is an oral N-methyl-d-aspartate receptor (NMDAR) Positive Allosteric Modulator (PAM) being developed for cognitive impairment in Huntington’s disease.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.